logo

For the Inventor, By the Inventor

San Francisco, CA, United States of America

The J. David Gladstone Institutes


USPTO Granted Patents = 90



Trademarks = 2

Forward Citations = 239

Loading Chart...
Loading Chart...

136 inventors (with patents filed for the assignee):

goldMedal Eric M Verdin (17 out of 23 patents)

silverMedal Yadong Huang (11 out of 13 patents)

bronzeMedal Warner C Greene (9 out of 15 patents)

4.  Lennart Mucke (9 out of 14 patents)

5.  Li Gan (8 out of 10 patents)

6.  Melanie Ott (8 out of 11 patents)

7.  Katerina Akassoglou (6 out of 13 patents)

8.  John Newman (5 out of 31 patents)

9.  Scott Michael Ulrich (5 out of 13 patents)

10.  Deepak Srivastava (5 out of 7 patents)

11.  Qin Xu (4 out of 4 patents)

12.  Erik Roberson (4 out of 4 patents)

13.  Karl H Weisgraber (4 out of 6 patents)

14.  Robert W Mahley (3 out of 5 patents)

15.  Steven M Finkbeiner (3 out of 7 patents)


Core Competencies:
Modified Mitochondrion
Induced Pluripotent Cells
CRISPR Activation
Latent Immunodeficiency Virus
Obesity Treatment
Automated Robotic Microscopy
Genome Editing Detection
Glucose Metabolism Regulation
Cardiomyocyte Generation
Neurodegenerative Disease
Tau Modulation
Neural Stem Cells

90 patents:

1. 12460230 - Modified mitochondrion and methods of use thereof (2025-11-04),
2. 12146166 - Generation of induced pluripotent cells by CRISPR activation (2024-11-19),
3. 11807852 - Compositions and methods for reactivating latent immunodeficiency virus (2023-11-07),
4. 11773051 - S-enantiomers of beta-hydroxybutyrate and butanediol and methods for using same (2023-10-03),
5. 11608308 - Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same (2023-03-21),
6. 11584931 - Methods and compositions for generating a deletion library and for identifying a defective interfering particle (DIP) (2023-02-21),
7. 11440948 - Modified non-natural NKG2D ligands that selectively deliver attached heterologous molecules to non-natural NKG2D receptors on car-cells (2022-09-13),
8. 11376242 - Methods and compositions for treating obesity and/or diabetes and for identifying candidate treatment agents (2022-07-05),
9. 11361527 - Automated robotic microscopy systems (2022-06-14),
10. 11236383 - Detection of genome editing (2022-02-01),
11. 11099172 - In vitro assays for inhibition of microglial activation (2021-08-24),
12. 11020463 - Method of determining cellular protein homeostasis (2021-06-01),
13. 10889538 - Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same (2021-01-12),
14. 10647658 - Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same (2020-05-12),
15. 10562839 - Medium chain fatty acid esters of β-hydroxybutyrate and butanediol and compositions and methods for using same (2020-02-18),
The J. David Gladstone Institutes is an independent, nonprofit biomedical research organization focused on improving human health through scientific discovery. With a mission to drive fundamental biological research and develop novel therapies for the treatment of diseases, Gladstone Institutes is committed to training future generations of scientists and collaborating with partners worldwide to accelerate the pace of scientific progress.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

90 Patents

#70 in San Francisco, CA

#957 in California

#4,005 in US

#8,279 in the World

...
San Francisco, CA, United States of America

The J. David Gladstone Institutes

Forward Citations = 239

136 inventors:

goldMedal Eric M Verdin (17 out of 23 patents)

silverMedal Yadong Huang (11 out of 13 patents)

bronzeMedal Warner C Greene (9 out of 15 patents)

4.  Lennart Mucke (9 out of 14 patents)

5.  Li Gan (8 out of 10 patents)

Please report any incorrect information to support@idiyas.com
Loading…